Bentham Science Logo

Track Your Manuscript:


Cardiovascular & Hematological Disorders-Drug Targets

Formerly: Current Drug Targets - Cardiovascular & Hematological Disorders

Volume 20, 4 Issues, 2020
ISSN: 2212-4063 (Online)
ISSN: 1871-529X (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Cardiovascular & Hematological Disorders-Drug Targets , Volume 13 - Number 2



The Serpin Solution; Targeting Thrombotic and Thrombolytic Serine Proteases in Inflammation

, 13(2): 99 - 110

Hao Chen, Jennifer A. Davids, Donghang Zheng, Marsha Bryant, Ilze Bot, Theo J.C. van Berckel, Erik Biessen, Carl Pepine, Kate Ryman, Ann Progulski-Fox, Lakshmyya Kesavalu, Richard Moyer, Grant McFadden and Alexandra Lucas


DOI: 10.2174/1871529X11313020003



Serpins for Diagnosis and Therapy in Cancer

, 13(2): 123 - 132

Donghang Zheng, Hao Chen, Jennifer Davids, Marsha Bryant and Alexandra Lucas


DOI: 10.2174/1871529X11313020005








Editor-in-Chief

Garry X. Shen
University of Manitoba
Winnipeg, MB
(Canada)

Biography
View Full Editorial Board

Journal History

Cardiovascular and Hematological Disorders-drug Targets was launched in 2001. Dr. Garry X. Shen serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.46

New eBook

Frontiers in Clinical Drug Research-Hematology



You can view the contents of this eBook [here] or purchase it [here].

Advertisement

STATISTICS AND DATA PRESENTATIONCovid Resource Center

Related Journals

Related eBooks

eBooks Catalog